Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.


Final Dividend (with Dividend Re-Investment Plan)


Entitlement subject Final Dividend (with Dividend Re-Investment Plan)
Entitlement description
Final dividend of RM0.05 per ordinary share
Ex-Date 13 Jul 2020
Entitlement date 14 Jul 2020
Entitlement time 5:00 PM
Financial Year End 31 Dec 2019
Share transfer book & register of members will be  to  closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date 12 Aug 2020
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 14 Jul 2020
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)
Entitlement indicator Currency
Entitlement in Currency Malaysian Ringgit (MYR)  0.0500
Options Available to Shareholders Cash or Securities


Cash^ Entitlement

Tax Indicator Tax Exempt / Non-taxable
Currency Malaysian Ringgit (MYR)
Amount 0.0500

or Securities

Re-invest Cash Entitlement into Securities
Entitlement Malaysian Ringgit (MYR)  0.0500
Company Name
Issue Price per Unit Malaysian Ringgit (MYR) 1.4100
Deadline To Respond 30 Jul 2020 05:00 PM
Securities Crediting Date 12 Aug 2020
Available/Listing Date 13 Aug 2020
Fractional Entitlement Cash in Lieu of Fraction
Malaysian Ringgit (MYR) 1.4100 per unit
Note: You will receive Cash^ if you do not Re-invest.

Registrar or Service Provider name, address, telephone no TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Wilayah Persekutuan



Remarks :
The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") has declared a single-tier final dividend of RM0.05 per ordinary share in Duopharma Biotech ("Duopharma Biotech Shares") in respect of the financial year ended 31 December 2019. The Board has also determined the dividend reinvestment plan ("DRP") would apply to the final dividend.

Following the above, on behalf of the Board, Mercury Securities Sdn Bhd had on 30 June 2020 announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM1.41 per Duopharma Biotech Share. 

This announcement is dated 30 June 2020.

Announcement Info

Stock Name DPHARMA
Date Announced 30 Jun 2020
Category Entitlement(Notice of Book Closure)
Reference Number ENT-29062020-00016
Corporate Action ID MY200629DRIP0001

View original